3,602
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas

, , &
Pages 1678-1687 | Received 02 Jan 2019, Accepted 03 Jun 2019, Published online: 26 Jun 2019

References

  • Dochez C, Bogers JJ, Verhelst R, Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine. 2014;32(14):1595–601. doi:10.1016/j.vaccine.2013.10.081.
  • Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011;103(5):368–83. doi:10.1093/jnci/djq562.
  • Thomas TL, Strickland O, Diclemente R, Higgins M. An opportunity for cancer prevention during preadolescence and adolescence: stopping human papillomavirus (HPV)-related cancer through HPV vaccination. J Adolesc Health. 2013;52(5,Supplement):S60–S68. doi:10.1016/j.jadohealth.2012.08.011.
  • Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–19. doi:10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F.
  • Emiko PM, Joseph A, Bocchini MD Jr, Hariri S, Harrell Chesson P, Robinette Curtis, MD PC, Mona Saraiya MD. Basic Information about HPV-associated cancers. Centers for disease control and prevention. [ Accessed 2014 Aug 24]. https://www.cdc.gov/cancer/hpv/basic_info/.
  • Centers for Disease Control and Prevention. HPV-associated cancers statistics. 2014. [Accessed 2015]. http://www.cdc.gov/cancer/hpv/statistics/index.htm.
  • Centers for Disease Control and Prevention. Emiko PM, Bocchini JA Jr, Susan Hariri MD, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. 2015. p. 300–03. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm.
  • Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini Jr JA, Unger ER. Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63(Rr–05):1–30.
  • Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014;13(2):235–46. doi:10.1586/14760584.2013.871204.
  • Lee LY, Garland SM. Human papillomavirus vaccination: the population impact. F1000Res. 2017;6:866. doi:10.12688/f1000research.10493.2.
  • Bloem P, Ogbuanu I. Vaccination to prevent human papillomavirus infections: from promise to practice. PLoS Med. 2017;14(6):e1002325. doi:10.1371/journal.pmed.1002230.
  • Hilton S, Hunt K, Bedford H, Petticrew M. School nurses’ experiences of delivering the UK HPV vaccination programme in its first year. BMC Infect Dis. 2011;11:226.
  • Bosch X, Harper D. Prevention strategies of cervical cancer in the HPV vaccine era. Gynecol Oncol. 2006;103(1):21–24. doi:10.1016/j.ygyno.2006.07.019.
  • Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomasvirus vaccination - updated recommendations of the advisory committee on immunization practice. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–08. doi:10.15585/mmwr.mm6549a5.
  • Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017;13(11):2713–22. doi:10.1080/21645515.2017.1363133.
  • Immunization and infectious diseases | healthy people 2020. 2015. [Accessed 2015 Aug 1]. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives.
  • Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years - United States, 2016. MMWR Recomm Rep. 2017;66(33):874–82. doi:10.15585/mmwr.mm6633a2.
  • Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 - United States. MMWR Morb Mortal Wkly Rep. 2013;62(29):591–95.
  • President’s Cancer Panel Annual Report 2012–2013. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. [ Accessed 2018 Aug 29]. http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/ExecutiveSummary.htm#sthash.PcA0EnNk.dpbs.
  • Newman PA, Logie CH, Lacombe-Duncan A, Baiden, P, Tepjan, S, Rubincam, C, Doukas, Nand Asey, F. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018;8(4):e019206. doi:10.1136/bmjopen-2017-019206.
  • Anderson A, Taylor Z, Georges R, Carlson-Cosentino M, Nguyen L, Salas M, Vice A, Bernal N, Bhaloo T. Primary care physicians’ role in parental decision to vaccinate with HPV vaccine: learnings from a South Texas hispanic patient population. J Immigr Minor Health. 2018;20(5):1236–42. doi:10.1007/s10903-017-0646-9.
  • Furgurson KF, Sandberg JC, Hsu FC, Mora DC, Quandt SA, Arcury TA. HPV knowledge and vaccine initiation among Mexican-Born farmworkers in North Carolina. Health Promot Pract. 2019;20(3):445–54. doi:10.1177/1524839918764671.
  • Fleming WS, Sznajder KK, Nepps M, Boktor SW. Barriers and facilitators of HPV vaccination in the VFC program. J Community Health. 2018;43(3):448–54. doi:10.1007/s10900-017-0457-x.
  • Sherman SM, Nailer E. Attitudes towards and knowledge about human papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK. PLoS One. 2018;13(4):e0195801. doi:10.1371/journal.pone.0195801.
  • Donahue KL, Hendrix KS, Sturm LA, Zimet GD. Human papillomavirus vaccine initiation among 9–13 year-olds in the United States. Prev Med Rep. 2015;2:892–98. doi:10.1016/j.pmedr.2015.10.003.
  • Brown B, Gabra MI, Pellman H. Reasons for acceptance or refusal of human papillomavirus vaccine in a California pediatric practice. Papillomavirus Res. 2017;3:42–45. doi:10.1016/j.pvr.2017.01.002.
  • Clark SJ, Cowan AE, Filipp SL, Fisher AM, Stokley S. Understanding non-completion of the human papillomavirus vaccine series: parent-reported reasons for why adolescents might not receive additional doses, United States, 2012. Public Health Rep. 2016;131(3):390–95. doi:10.1177/003335491613100304.
  • Rutten LJ, St Sauver JL, Beebe TJ, Wilson PM, Jacobson DJ, Fan C, Breitkopf CR, Vadaparampil ST, Jacobson RM. Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: association with initiation and completion rates. Vaccine. 2017;35(1):164–69. doi:10.1016/j.vaccine.2016.11.012.
  • Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolesc Health. 2014;54(3):282–88. doi:10.1016/j.jadohealth.2013.12.011.
  • Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011;165(6):547–53. doi:10.1001/archpediatrics.2011.73.
  • Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, Snow M, Cory J, Stokley S, Roark J, Kempe A. Primary care physicians’ perspectives about HPV vaccine. Pediatrics. 2016;137(2):e20152488. doi:10.1542/peds.2015-2488.
  • Hswen Y, Gilkey MB, Rimer BK, Brewer NT. Improving physician recommendations for human papillomavirus vaccination: the role of professional organizations. Sex Transm Dis. 2017;44(1):42–47. doi:10.1097/OLQ.0000000000000543.
  • Kornides ML, McRee AL, Gilkey MB. Parents who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018;18(2S):S37–S43. doi:10.1016/j.acap.2017.06.008.
  • Javaid M, Ashrawi D, Landgren R, Stevens L, Bello R, Foxhall L, Mims M, Ramondetta L. Human papillomavirus vaccine uptake in texas pediatric care settings: a statewide survey of healthcare professionals. J Community Health. 2017;42(1):58–65. doi:10.1007/s10900-016-0228-0.
  • Nickel B, Dodd RH, Turner RM, Waller J, Marlow L, Zimet G, Ostini R, McCaffery K. Factors associated with the human papillomavirus (HPV) vaccination across three countries following vaccination introduction. Prev Med Rep. 2017;8:169–76. doi:10.1016/j.pmedr.2017.10.005.
  • Ganczak M, Owsianka B, Korzen M. Factors that predict parental willingness to have their children vaccinated against HPV in a Country with low HPV vaccination coverage. Int J Environ Res Public Health. 2018;15:4. doi:10.3390/ijerph15061188.
  • Lacombe-Duncan A, Newman PA, Baiden P. Human papillomavirus vaccine acceptability and decision-making among adolescent boys and parents: A meta-ethnography of qualitative studies. Vaccine. 2018;36(19):2545–58. doi:10.1016/j.vaccine.2018.02.079.
  • Cipriano JJ, Scoloveno R, Kelly A. Increasing parental knowledge related to the human papillomavirus (HPV) vaccine. J Pediatr Health Care. 2018;32(1):29–35. doi:10.1016/j.pedhc.2017.06.006.
  • Nehme E, Patel D, Oppenheimer D, Karimifar M, Elerian N, Lakey D. Missed opportunity: human papillomavirus vaccination in Texas. Austin, TX: The University of TexasScience Center at Tyler/University of Texas System; 2017. https://static1.squarespace.com/static/5756c8d1356fb02fbe7d19eb/t/5afc9508562fa76ce54a07e8/1526502668857/hpv_vaccination_in_texas_cit.pdf.
  • Overview of HIV/AIDS in the Texas-Mexico Border Region | AIDS Education and Training Centers National Coordinating Resource Center (AETC NCRC). 2015. [ Accessed 2015 Aug 1]. http://aidsetc.org/border/profile-texas.
  • Brown A. The unique challenges of surveying U.S. Latinos. Pew Research Center; 2015. [Accessed 2015 Aug 1]. https://www.pewresearch.org/methods/2015/11/12/the-unique-challenges-of-surveying-u-s-latinos/.
  • Evans B, Quiroz RS, Athey L, McMichael, J., Albright, V., O’Hegarty, M. and Caraballo, R.S. Customizing survey methods to the target population - innovative approaches to improving. 2008. [Accessed 2015 Aug 1]. https://www.rti.org/sites/default/files/resources/evans_aapor08_paper.pdf.
  • O’Hegarty M, Pederson LL, Thorne SL, Caraballo RS, Evans B, Athey L, McMichael J. Customizing survey instruments and data collection to reach hispanic/latino adults in border communities in Texas. Am J Public Health. 2010;100(Suppl 1):S159–S164. doi:10.2105/AJPH.2009.167338.
  • Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Women’s Health. 2009;18(11):1793–99. doi:10.1089/jwh.2008.1266.
  • Center for Reproductive Rights. Nuestro voz, nuestro salud, nuestro Texas: the fight for women’s reproductive health in the Rio Grade Valley. New York (NY): Center for Reproductive Rights; 2015. [Accessed 2015 Aug 1]. https://reproductiverights.org/press-room/new-investigation-details-devastating-impact-of-texas-family-planning-cuts-on-latinas.
  • CDC. HPV-associated cancers rates by race and ethnicity. Centers for Disease Control and Prevention. Published 2017. 2017 Jul 17 [Accessed 2018 Jun 12]. https://www.cdc.gov/cancer/hpv/statistics/race.htm.
  • Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015;24(11):1673–79. doi:10.1158/1055-9965.EPI-15-0326.
  • Hanson KE, Koch B, Bonner K, McRee AL, Basta NE. National trends in parental human papillomavirus vaccination intentions and reasons for hesitancy, 2010–2015. Clin Infect Dis. 2018;67(7):1018–26. doi:10.1093/cid/ciy232.
  • Katz ML, Krieger JL, Roberto AJ. Human papillomavirus (HPV): college male’s knowledge, perceived risk, sources of information, vaccine barriers and communication. J Mens Health. 2011;8(3):175–84. doi:10.1016/j.jomh.2011.04.002.
  • McKee C, Bohannon K. Exploring the reasons behind parental refusal of vaccines. J Pediatr Pharmacol Ther. 2016;21(2):104–09. doi:10.5863/1551-6776-21.2.104.
  • Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-based socioeconomic factors and human papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2017;18(1):19. doi:10.1186/s12889-017-4567-2.
  • Cartmell KB, Young-Pierce J, McGue S, Alberg, A.J., Luque, J.S., Zubizarreta, M. and Brandt, H.M. Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. Papillomavirus Res. 2018;5:21–31. doi:10.1016/j.pvr.2017.11.003.
  • Marlow LA, Zimet GD, McCaffery KJ, Ostini R, Waller J. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013;31(5):763–69. doi:10.1016/j.vaccine.2012.11.083.
  • Thomas TL, Strickland OL, Mothers HM, Fathers S. Human papillomavirus immunization practices. Fam Community Health. 2017;40(3):278–87. doi:10.1097/FCH.0000000000000104.
  • Valdez A, Stewart SL, Tanjasiri SP, Levy V, Garza A. Design and efficacy of a multilingual, multicultural HPV vaccine education intervention. J Commun Healthc. 2015;8(2):106–18. doi:10.1179/1753807615Y.0000000015.
  • Morales-Campos DY, Parra-Medina D. Predictors of human papillomavirus vaccine initiation and completion among Latino mothers of 11- to 17-year-old daughters living along the Texas-Mexico Border. Fam Community Health. 2017;40(2):139–49. doi:10.1097/FCH.0000000000000144.
  • Reiter PL, Gerend MA, Gilkey MB, Perkins, R.B., Saslow, D., Stokley, S., Tiro, J.A., Zimet, G.D. and Brewer, N.T. Advancing human papillomavirus vaccine delivery: 12 priority research gaps. Acad Pediatr. 2018;18(2S):S14–S16. doi:10.1016/j.acap.2017.04.023.
  • Cheruvu VK, Bhatta MP, Drinkard LN. Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National immunization survey - teen 2008–2012. BMC Pediatr. 2017;17(1):52. doi:10.1186/s12887-017-0969-7.
  • Centers for Disease Control and Prevention. Clinician FAQ: CDC recommendations for HPV vaccine 2-dose schedules. Published 2016. accessed 2016 Nov 30. [accessed 2018]. https://www.cdc.gov/hpv/downloads/hcvg15-ptt-hpv-2dose.pdf.
  • Centers for Disease Control and Prevention. Clinician FAQ: CDC recommendations for HPV vaccine 2-dose schedules. 2016. [Accessed 2015 Aug 1]. https://www.cdc.gov/hpv/hcp/2-dose/clinician-faq.html.